Search for: "Teva USA"
Results 21 - 40
of 714
Sorted by Relevance
|
Sort by Date
25 Nov 2015, 9:59 pm
Teva Pharmaceuticals USA Inc., in a decision handed down earlier this month; the decision provides another example of the Court setting forth the contours of the scope of the... [read post]
1 Apr 2019, 9:59 pm
Teva Pharmaceuticals USA, Inc., the Federal Circuit reversed a decision by the U.S. [read post]
24 Feb 2022, 8:23 pm
Teva Pharmaceuticals USA, Inc., the panel majority affirming a District Court decision that the claimed invention was indeed obvious. [read post]
16 Sep 2013, 9:59 pm
Teva Pharmaceuticals USA. [read post]
17 Jul 2022, 9:15 am
On July 11, Teva Pharmaceuticals USA filed a Petition for Writ of Certiorari to the U.S. [read post]
31 Oct 2011, 5:42 pm
San Diego - Last week, Pfizer announced its victory in a patent infringement battle with Teva Pharmaceuticals USA, Inc. in the United States District Court for the Eastern District of Virginia. [read post]
30 Jun 2011, 9:18 pm
USA, No. 10-1070 (U.S. 2011) In a little-noticed decision two weeks ago, the Supreme Court vacated the Federal Circuit's decision in Teva v. [read post]
18 Apr 2014, 1:04 pm
In a one-page ruling, Roberts said he was not convinced that Teva Pharmaceuticals USA, Inc., would suffer serious harm from the competition because it can later sue the generic companies for damages if its key patent on the drug Copaxone is ultimately upheld. [read post]
3 Jan 2015, 9:41 am
On January 20, 2015, the Supreme Court issued its decision in Teva Pharmaceuticals USA, Inc. v. [read post]
24 Feb 2009, 2:22 pm
USA, Inc., No. 2009–1071 (Fed. [read post]
20 Jan 2015, 11:23 am
Teva Pharmaceuticals USA, Inc. v. [read post]
7 Apr 2014, 8:50 am
Faced with the prospect in about six weeks of competition from lower-cost versions of its highly valuable drug Copaxone, Teva Pharmaceuticals USA, Inc. [read post]
26 Jun 2018, 8:51 pm
Teva Pharmaceuticals USA Inc., Docket No. 17-1229.... [read post]
26 Jun 2018, 8:17 am
Teva Pharmaceuticals USA, Inc. [read post]
1 Sep 2015, 9:59 pm
Patent No. 7,772,209, owned by Lilly, would be infringed by the ANDA products for which Defendants Teva Parenteral Medicines, Inc.; Teva Pharmaceuticals USA, Inc.; APP Pharmaceuticals, LLC; Barr Laboratories, Inc.; and Pliva Hrvatska D.O.O. sought approval to market (opinion).... [read post]
21 Nov 2017, 1:25 pm
Indianapolis, Indiana – Attorneys for Plaintiff, Eli Lilly and Company of Indianapolis, Indiana, filed suit in the Southern District of Indiana alleging that Defendants, Actavis LLC of Parsippany, New Jersey; Teva Pharmaceuticals USA of North Wales, Pennsylvania; and Teva Pharmaceutical Industries, Ltd. of Petach Tikva, Israel infringed its rights in United States Patent No. 7,772,209 (“the ’209 patent”) for “Antifolate Combination… [read post]
13 Aug 2020, 9:59 pm
Teva Pharmaceuticals USA, Inc., affirmed a District Court's finding that the asserted claims to a pharmaceutical formulation were indefinite. [read post]
9 Jan 2017, 9:36 am
In other words, Copaxone should remain a $4 billion drug, annually.link to Pantagraph: http://www.pantagraph.com/business/investment/markets-and-stocks/factors-that-sent-teva-pharmaceutical-industries-ltd-sliding-in/article_74234eee-a5ec-5c58-a54b-82597151b1e6.htmlPatents covering "three per week" dosing were not at issue in the Supreme Court case of Teva Pharmaceuticals USA, Inc. v. [read post]
23 Nov 2018, 8:03 pm
Teva Pharmaceuticals USA Inc. case beginning at 4:00 pm (Eastern) on December 4, 2018 at the American University Washington College of Law in Washington, DC. [read post]
20 Aug 2009, 12:52 am
USA, Inc. et al., 3-07-cv-01596 (NJD August 19, 2009, Findings of Fact & Conclusions of Law) (Brown, J.) [read post]
